INTC
Intel Corporation
INTC has the edge over VRNS overall, supported by stronger fundamentals and stronger modeled upside.
VRNS
Varonis Systems, Inc.
VRNS has lower modeled downside risk, despite its lower overall score.
INTC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Healthy | |
| Healthy |
INTC's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.
VRNS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Healthy | |
| Unavailable |
VRNS's revenue and cash flow are currently healthy, but its profitability is weak. There isn't enough data to rate its balance sheet.
INTC PE Valuation
INTC has no meaningful PE right now: it lost money over the past year.
VRNS PE Valuation
VRNS has no meaningful PE right now: it lost money over the past year.
INTC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Broad | |
| Low |
Analysts expect earnings and revenue growth for INTC, with profitability improving. However, they disagree widely on these estimates.
VRNS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect strong earnings and revenue growth for VRNS, with profitability improving. However, they disagree widely on these estimates.
INTC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.41 | — |
| Q3 2026 | -$2.39 | -24000% |
| Q2 2026 | -$2.09 | +$2.68 |
| Q1 2026 | -$0.60 | +$3.88 |
| Q4 2025 | -$0.06 | +$4.32 |
| Q3 2025 | $0.01 | +$3.72 |
| Q2 2025 | -$4.77 | -2088% |
| Q1 2025 | -$4.48 | -562% |
| Q4 2024 | -$4.38 | -1195% |
INTC has the edge over VRNS on earnings, with more consistent year-over-year improvement.
VRNS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.36 | — |
| Q3 2026 | -$1.32 | -$0.30 |
| Q2 2026 | -$1.22 | -$0.30 |
| Q1 2026 | -$1.13 | -$0.32 |
| Q4 2025 | -$1.13 | -$0.27 |
| Q3 2025 | -$1.02 | -$0.27 |
| Q2 2025 | -$0.92 | -$0.12 |
| Q1 2025 | -$0.81 | +$0.13 |
| Q4 2024 | -$0.86 | +$0.06 |
VRNS lost $1.32 per share over the past year, a bigger loss than the year before.
INTC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16.5B | +21% |
| Q2 2026 | $16.1B | +25% |
| Q1 2026 | $13.6B | +7.2% |
| Q4 2025 | $13.7B | -4.1% |
| Q3 2025 | $13.7B | +2.8% |
| Q2 2025 | $12.9B | +0.2% |
| Q1 2025 | $12.7B | -0.4% |
| Q4 2024 | $14.3B | -7.4% |
INTC's revenue is recovering but still below its 2021 peak: $16.5B last quarter, up 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +10 points |
| Q2 2026 | 11% | +36 points |
| Q1 2026 | -23% | -21 points |
| Q4 2025 | 4.2% | +1.4 points |
| Q3 2025 | 5% | +73 points |
| Q2 2025 | -25% | -9.4 points |
| Q1 2025 | -2.4% | +6 points |
| Q4 2024 | 2.9% | -14 points |
INTC has the edge over VRNS on profitability, with a higher operating margin.
VRNS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $189.5M | +17% |
| Q2 2026 | $180M | +18% |
| Q1 2026 | $173.1M | +27% |
| Q4 2025 | $173.4M | +9.4% |
| Q3 2025 | $161.6M | +9.1% |
| Q2 2025 | $152.2M | +17% |
| Q1 2025 | $136.4M | +20% |
| Q4 2024 | $158.5M | +2.9% |
VRNS has the edge over INTC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -25% | -2.9 points |
| Q2 2026 | -23% | +1.4 points |
| Q1 2026 | -26% | +6.4 points |
| Q4 2025 | -17% | -6.4 points |
| Q3 2025 | -22% | -6.3 points |
| Q2 2025 | -24% | -1.9 points |
| Q1 2025 | -32% | +9.7 points |
| Q4 2024 | -11% | -7.7 points |
VRNS's operating margin was −25% last quarter, down 2.9 points from the same quarter a year ago.
INTC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +774% |
| Q2 2026 | $4.5B | +$6B |
| Q1 2026 | -$2.5B | +$1.8B |
| Q4 2025 | $800M | +$3.5B |
| Q3 2025 | $121M | +$2.5B |
| Q2 2025 | -$1.5B | +$1.9B |
| Q1 2025 | -$4.4B | +$2.8B |
| Q4 2024 | -$2.7B | -$597M |
INTC has the edge over VRNS on cash flow, with more consistent year-over-year improvement.
VRNS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26.6M | -13% |
| Q2 2026 | $20.7M | +15% |
| Q1 2026 | $50.1M | -24% |
| Q4 2025 | $20.7M | +4.1% |
| Q3 2025 | $30.4M | +43% |
| Q2 2025 | $18M | +65% |
| Q1 2025 | $65.7M | +16% |
| Q4 2024 | $19.9M | +140% |
VRNS generated $118M in free cash flow over the past year, down 12% from the year before.
INTC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.0x | Healthy |
| Q2 2026 | 3.1x | Elevated |
| Q1 2026 | 3.9x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 4.0x | Elevated |
| Q1 2025 | 69.6x | High |
| Q3 2024 | 23.8x | High |
| Q2 2024 | 4.3x | High |
INTC's net debt is about 2.0 years of its operating earnings (EBITDA), down from 4.0 years a year ago.
VRNS Net Leverage
VRNS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
INTC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.1 | Neutral |
| Stochastic | 7.7 | Oversold |
INTC's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
VRNS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.7 | Neutral |
| Stochastic | 86.9 | Overbought |
VRNS's weekly RSI is 63 (neutral) and its Stochastic is 87 (overbought).
INTC PE vs Technology Sector
| Metric | INTC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
INTC has no meaningful PE right now: it lost money over the past year.
VRNS PE vs Technology Sector
VRNS has no meaningful PE right now: it lost money over the past year.
INTC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $88.4 | 31% below |
| 20 week MA | $95.3 | 36% below |
| 50 week MA | $79.3 | 23% below |
| 100 week MA | $52.1 | 18% above |
| 200 week MA | $42.5 | 44% above |
INTC has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 44% above its 200-week average.
VRNS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $48.5 | 1.1% above |
| 20 week MA | $46.1 | 6.5% above |
| 50 week MA | $35.7 | 37% above |
| 100 week MA | $41.6 | 18% above |
| 200 week MA | $40.6 | 21% above |
VRNS has the edge over INTC on trend strength, trading above more of its moving averages.
INTC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $60.1 | $47.1 | -22% |
| 2021 | $47.1 | $51.3 | +9% |
| 2022 | $51.3 | $26.1 | -49% |
| 2023 | $26.1 | $50.3 | +93% |
| 2024 | $50.3 | $20.3 | -60% |
| 2025 | $20.3 | $36.2 | +78% |
| 2026 YTD | $36.2 | $61.2 | +69% |
INTC has the edge over VRNS on returns for 2026, with the stronger performance.
VRNS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $26.2 | $56.7 | +117% |
| 2021 | $56.7 | $49.2 | -13% |
| 2022 | $49.2 | $23.4 | -52% |
| 2023 | $23.4 | $45.3 | +93% |
| 2024 | $45.3 | $45.0 | -0.7% |
| 2025 | $45.0 | $33.6 | -25% |
| 2026 YTD | $33.6 | $49.1 | +46% |
VRNS's yearly returns have swung widely, from +117% in 2020 to −52% in 2022. It's up 46% so far in 2026.